loader2
Partner With Us NRI

Neogen Chemicals Ltd share Price Today

Company details

1,340.00
1,397.05
1,176.00
1,859.30
6M Return -20.08%
1Y Return -16.52%
Mkt Cap.(Cr) 3,607.21
Volume 21,982
Div Yield 0.21%
OI
-
OI Chg %
-
Volume 21,982

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Growth momentum maintained; focus on new capex
About The Stock

    Commencing operations in 1991, Neogen Chemicals manufactures specialty organic bromine-based chemical compounds as well as specialty inorganic lithium-based chemicals compounds.

    • The company’s products find application in pharmaceutical intermediates, agrochemical intermediates, engineering fluids, polymers additives and water treatment chemicals, to name a few
    • Neogen has two segments viz. (i) organic chemicals, (ii) inorganic chemicals of which organic chemical constitute ~80% of overall revenue while the rest comes from inorganic chemicals
Q3FY23

    Numbers were marginally in line with our estimates on the revenue front while EBITDA came in below estimates due to lower GPM.

    • Reported revenue growth of 40% YoY to ₹ 186.3 crore, led by higher growth from both organic chemicals ₹ 136 crore (up 29% YoY) and inorganic chemicals ₹ 50.3 crore (up 86% YoY)
    • Gross margins fell 91 bps YoY to 43.2% while EBITDA margin declined 177 bps YoY to 16.2%. Absolute EBITDA was up 27% YoY to ₹ 30.1 crore
    • PAT increased 41% YoY to ₹ 14.8 crore

Click here for full recommendation

Research view on more stocks

Neogen Chemicals announced Q2FY24 results:

  • In Q2FY24, revenue was Rs 161.7 crore, with a growth of 9% YoY. This was achieved despite the challenging external environment aggravated by global inventory destocking, the slowdown in key export markets, and geopolitical uncertainties among others. Recent capacity expansions, stable demand, and contributions from BuLi Chem supported the growth momentum.
  • EBITDA at Rs 25.9 crore was higher by 7% YoY. Growth in profitability was reflected by an improved product mix and a reduction in key input and RM costs.
  • Profit after tax (PAT) stood at Rs 7.9 crore, lower by 20% YoY compared to Rs 9.9 crore in Q2FY23. PAT was lower due to higher finance costs and depreciation related to ongoing CAPEX initiatives undertaken by the Company.
  • Strategic debt repayment from recent preference share proceeds will help lower the finance expenses in the near term.
  • Earnings per share (EPS) for Q2FY24 stood at Rs 3.17 per share (Rs. 3.95 per share in Q2FY23).

Commenting on the Q2FY24 performance, Haridas Kanani, Chairman & Managing Director, Neogen Chemicals said, “I am pleased to share that we have maintained a consistent performance despite persistent external headwinds that have adversely impacted the end-user demand. We achieved a 9% growth in revenues along with a 7% improvement in EBITDA on a YoY basis. Positive contributions from recently acquired BuLi Chem, rationalisation of key RM & input costs, along with efficient inventory management were notable drivers of performance during the quarter.

In a significant development, we recently raised ~Rs 253 crore through preferential allotment to leading institutional investors. I would like to express my appreciation for the trust placed in us and the support extended toward our future growth endeavors. We will carefully deploy these funds to establish a strong presence in the Battery Materials space while sustaining the growth momentum in the existing business.

We are rapidly progressing along the outlined growth path. BuLi Chem has started contributing and also achieved break-even. This will further ramp up as we move along. The contribution from value-added products is also increasing, and our endeavor is to add more complex products by leveraging our R&D expertise and manufacturing capabilities. Our efforts related to Battery Materials are advancing successfully. Our project using MUIS technology is evolving positively, and we are on schedule to finalize the design work by the end of this year. Our interactions with key customers for both Lithium Electrolyte Salts and Electrolytes are making good progress, and we are seeing strong interest from international customers, especially for Electrolyte Salts. We are confident of garnering a significant share as the transition to EVs gains momentum.

Overall, we are well poised to capitalize on the upcoming opportunities. Building upon the solid foundation, we remain steadfast in our pursuit to not only elevate our performance momentum but also consistently enhance value for our stakeholders.”

Result PDF

View Other Company Results

Neogen Chemicals Ltd shares SWOT Analysis

Strengths (4)

  • Annual Net Profits improving for last 2 years
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge

Weakness (9)

  • MFs decreased their shareholding last quarter
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years
  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (2)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)

Resistance and support

R1 1,396.2
R2 1,425.2
R3 1,453.3
Pivot

1,368.12

S1 1,339.2
S2 1,311.1
S3 1,282.1
EMA SMA
1,319.9
1,332.2
1,388.4
1,443.5
1,291.2
1,312.3
1,396.6
1,516.4
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-04-12 1654.79 148944 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2023-04-12 1655.54 148944 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-04-11 1558.91 127438 NSE
Name Category Shares
Haridas Thakarshi Kanani PROMOTER 45.11%
Harin Haridas Kanani PROMOTER 7.58%
Pallika Haridas Kanani PROMOTER 3.78%

OUR RESEARCH VIEW

Investment recommendation
Growth momentum maintained; focus on new capex
Call Date
20 Feb 2023
Entry Price 1,295.00
Target Price 1,535.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Neogen Chemicals Ltd Stocks COMPARISON

Financials( in Cr) Neogen Chemicals Ltd Pidilite Industries Ltd SRF Ltd Linde India Ltd Gujarat Fluorochemicals Ltd
Price 1,367.30 2,871.80 2,529.95 7,200.05 3,598.60
% Change -1.35 -0.25 0.46 4.09 2.10
Mcap Cr 3,607.21 146,062.33 74,994.04 61,404.91 39,530.62
Revenue TTM Cr 686.18 11,799.10 14,870.25 3,135.52 5,684.66
Net Profit TTM Cr 49.97 1,288.87 2,162.34 538.06 1,323.05
PE TTM 109.98 85.30 50.85 143.18 59.22
1 Year Return -16.52 21.19 2.77 73.12 11.72
ROCE 13.01 24.24 21.98 16.29 29.38
ROE 10.84 18.93 22.89 14.70 27.07
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 482.52 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 24,721.64 -7,659.83
LAST 3M 80,167.53 39,149.62
LAST 6M 140,394.95 70,735.56
LAST 12M 215,454.79 197,509.84

Neogen Chemicals Ltd Information

Stock PE (TTM)
109.98
Promoter Holding
56.89%
Book Value
284.4509
ROCE
13.01%
ROE
10.84%
Description
  • Neogen Chemicals Limited was incorporated as a private limited company with the name Neogen Chemicals Private Limited` on March 7, 1989 in Thane, Maharashtra. Subsequently, pursuant to a special resolution passed by the shareholders of the Company on May 2, 1998, the Company was converted to a public limited company and the name of the Company was changed to Neogen Chemicals Limited` on July 2, 1998. Neogen is one of India`s leading manufacturers of bromine-based, and lithium-based, specialty chemicals. Specialty chemicals are those chemicals that impart different properties to a variety of products (i.e. the effect that specialty chemicals have varies based on the product) and have a high degree of value addition. Specialty chemicals are, also generally, in the Indian context, manufactured in smaller volumes when compared to non-specialty chemicals. Specialty chemicals, including bromine and lithium-based compounds, comprise pharmaceutical intermediates, agrochemical intermediates, engineering fluids, electronic chemicals, polymers additives, water treatment chemicals, construction chemicals and flavours and fragrances. Specialty chemicals are widely used for specialized applications to meet industry-specific requirements and can be classified based on application industries. Additionally, certain specialty chemicals find application in multiple industries. The Company manufactures specialty organic bromine-based chemical compounds (Bromine Compounds) and other specialty organic chemical compounds as well as specialty inorganic lithium-based chemicals compounds (Lithium Compounds and together with the Bromine Compounds the Products). The Company commenced its business operations in 1991, at Mahape, Navi Mumbai manufacturing facility with a few Bromine Compounds and Lithium Compounds. Over the years it has expanded its range of products and, presently, manufacture an extensive range of specialty chemicals which find application across various industries in India and globally. As on February 28, 2019, the company has manufactured an aggregate of 198 products comprising 181 organic chemicals and 17 inorganic chemicals. In addition to manufacturing its standard products, the company also undertakes custom synthesis and contract manufacturing. In custom synthesis the product is developed and customized primarily for a specific customer, but process know-how and technical specifications are developed in-house by the company. Further, it has, more recently, also commenced contract manufacturing where, the product is developed under confidentiality for a single customer using the process know-how and the technical specifications provided by the customer. Contract manufacturing has enabled the company to increase its bouquet of product offering. The Company differentiates itself in the contract manufacturing space by additionally offering process innovation, which, generally, reduces the overall operating costs for their customers. The Company operates out of its manufacturing facilities located in Mahape, Navi Mumbai in Maharashtra (Mahape Facility) and Karakhadi, Vadodara in Gujarat (Vadodara Facility). The Corporate office is located in Thane, Maharashtra. The Company is, presently, developing a green-field manufacturing unit in Dahej SEZ, in Gujarat (Proposed Dahej Facility) and are also proposing to expand its operations in Karakhadi, Vadodara (Proposed Vadodara Facility). Its manufacturing facilities in aggregate are spread across approximately 40 acres with an additional 12 acres of leased property in Dahej SEZ. Its manufacturing units at Vadodara and Mahape also contain research and development (R&D) units comprising a dedicated 20 member in-house team. Neogen Chemicals came out with an Initial Public Offering (IPO) of 6,155,813 equity shares of Face Value of Rs 10 each for cash at a price of Rs 215 per equity share (including a share premium of Rs 205 per equity share) aggregating Rs132.35 Crores. The offer comprises of a fresh issue of 3,255,813 equity shares aggregating Rs 70 crores by the company (fresh issue) and an offer for sale of 1,699,600 equity shares by Haridas Thakarshi Kanani (promoter selling shareholder) and 1,200,400 equity shares by Beena Haridas Kanani (promoter group selling shareholder, and along with the promoter selling shareholder aggregating Rs 62.35 Crores. The face value of equity shares is Rs 10 each. The IPO was priced at Rs 215 per share.

Registered Address

1002 10th Flr Opp Cadbury Junc, Dev Corpora Bldg Off Pok RdNo2, Thane, Maharashtra, 400601

Tel : 91-22-2549 7300
Email : investor:neogenchem.com
Website : http://www.neogenchem.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 542665
NSE Code : NEOGEN
Book Closure Date (Month) : Aug/Sep
BSE Group : A
ISIN : INE136S01016

FAQ’s on Neogen Chemicals Ltd Shares

You can buy Neogen Chemicals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Neogen Chemicals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 18, 2024 03:53 PM the closing price of Neogen Chemicals Ltd was ₹ 1,367.30.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 18, 2024 03:53 PM, the market cap of Neogen Chemicals Ltd stood at ₹ 3,607.21.

The latest PE ratio of Neogen Chemicals Ltd as of Apr 18, 2024 03:53 PM is 109.98

The latest PB ratio of Neogen Chemicals Ltd as of Apr 18, 2024 03:53 PM is 0.21

The 52-week high of Neogen Chemicals Ltd share price is ₹ 1,859.30 while the 52-week low is ₹ 1,176.00

According to analyst recommendations, Neogen Chemicals Ltd Share has a “Buy” rating for the long term.

Download Our

Download App
market app